The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
"Whilst this is clearly disappointing, our plans do not include any contribution from COVID-19 antigen tests..."
This is somewhat reassuring. Sounds like they have not been expecting any sales from VISITECT, so hopefully this shouldn't affect the bottom line
"Currently, with insufficient demand for the professional-use test, the Company does not plan to commission further studies at this time."
Sounds like they were ready to write the VISITECT product off as a dead duck anyway.
Does anyone know if we can view this conference?
Nice. Finished 7% up at 375p. So I think it'll probably get to 400p before the end of the month, perhaps by the 22nd.
I see a placeholder in my shares account the extra "EXCESS APP (169P)" shares a opted for in the open offer. I take it that yesterday's RNS ("Open Offer will not take place") means that those shares will disappear and the money returned? Or did yesterday's RNS refer to a different Open Offer?
Maybe. I'd tentatively predict up 5% to 370p by the end of the week, and up 15% to 400p by the end of the month.
40% of EVR revenue and 85% of their steel production is in Russia. What is the chance that sanctions will prevent EVR selling? I assume very high, explaining the recent 85% drop in share price.
Risky business!